Skip to main content
Clinical Trials/CTRI/2024/11/077211
CTRI/2024/11/077211Not yet recruitingNot Applicable

clinicopathological study of women with endometrial hyperplasia

maulana azad medical college1 site in 1 country50 target enrollmentStarted: December 10, 2024Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
50
Locations
1
Primary Endpoint
treatment outcome of women with endometrial hyperplasia after 6 months

Study Overview

Brief Summary

patients visiting LNH OPD with  already diagnosed  histopathology of endometrial hyperplasia between age group of 35-65 years will be enrolled into the study. they will be given treatment according to the latest RCOG /ACOG guidelines and followed up at 6 weeks and 6 months with symtpoms and histopatholgy as per follow up guidelines. various risk factors that are already established with the risk for endometrial hyperplasia will be studied and association between the type of disease and risk factors will be evaluated.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
35.00 Year(s) to 65.00 Year(s) (—)
Sex
Female

Inclusion Criteria

  • all patients visiting the OPD between 35-65 years.

Exclusion Criteria

  • women below 35 years and above 65 years no males.

Outcomes

Primary Outcomes

treatment outcome of women with endometrial hyperplasia after 6 months

Time Frame: at 6 weeks and 6 months

Secondary Outcomes

  • association of risk factors to endometrial hyperplasia type(percentage wise type of disease associated with known risk factors)

Investigators

Sponsor Class
Government medical college
Responsible Party
Principal Investigator
Principal Investigator

priya mehar

maulana azad medical college

Study Sites (1)

Loading locations...

Similar Trials

Clinicopathological study of women with... | Clinical Trial